Undifferentiated Stem Cell Culture System Using KOSR Medium
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current culture systems for human embryonic stem cells (hESCs) are labor-intensive, variable, and do not allow for large-scale production of standardized, homogenous undifferentiated cells, often resulting in background differentiation and the need for animal-derived components.
Innovation Solution
A culture system using Neurobasal™ medium supplemented with knockout serum replacement (KOSR) supports the expansion and long-term cultivation of undifferentiated pluripotent hESCs in suspension, eliminating the need for animal-derived components and promoting directed or spontaneous differentiation into specific somatic cell types.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional culture systems are used for hESC propagation, then cells can be maintained in culture, but the systems are labor-intensive and do not allow for large-scale production
Solution Approach 1:
The patent replaces manual mechanical operations (pipetting, manual passage, physical separation) with an automated microfluidic system that uses computer-controlled pumps, valves, and chambers to perform all culture operations automatically, thereby enabling large-scale production while reducing labor intensity
Solution Approach 2:
The patent changes the physical and chemical parameters of the culture system by using defined media compositions, controlled oxygen tension (5% O2), specific pH levels, and temperature (37°C) to optimize cell proliferation and maintain pluripotency, allowing for standardized large-scale production
2Manufacturing precision
If conventional culture systems are used, then cells can be propagated, but the systems are variable and do not produce standardized homogenous cells
Solution Approach 1:
The patent standardizes culture conditions by precisely controlling media composition (defined components without animal-derived products), oxygen tension (5% O2), pH (7.2-7.4), and temperature (37°C), ensuring reproducible and standardized cell populations across multiple passages
Solution Approach 2:
The patent incorporates monitoring and feedback mechanisms where cell morphology, marker expression (SSEA-1, TRA-1-60, TRA-1-81), and proliferation rates are continuously assessed to maintain homogeneous undifferentiated cell populations and adjust culture conditions as needed
3Stability of the object's composition
If conventional culture systems are used, then hESCs can be maintained, but background differentiation occurs
Solution Approach 1:
The patent maintains pluripotency by precisely controlling culture parameters including defined media composition with growth factors (FGF-2, EGF, bFGF), oxygen tension (5% O2), and temperature (37°C), which prevents spontaneous differentiation and maintains stable cell composition
Solution Approach 2:
The patent uses specific growth factors and signaling molecules as intermediaries that actively prevent differentiation and maintain stem cell identity, while also using inhibitors of differentiation pathways to block unwanted cellular changes
4Productivity
If animal-derived components are used in culture systems, then cell growth is supported, but the systems require animal-derived components
Solution Approach 1:
The patent extracts and eliminates animal-derived components (fetal bovine serum, animal feeders, animal-derived growth factors) from the culture system and replaces them with defined synthetic media and human cell-based feeders, maintaining cell growth without animal products
Solution Approach 2:
The patent changes the chemical composition parameters of the culture media by using defined synthetic formulations that replicate the growth-supporting functions of animal-derived components through specific combinations of amino acids, vitamins, and growth factors
Data Source
AI summary
The present application discloses methods expanding SCs in an undifferentiated state, the methods comprising incubating undifferentiated SCs in suspension within a culture system comprising basic medium and knockout serum replacement (KOSR). The methods may also be applicable for selective spontaneous or directed differentiation of SCs into a selected population of somatic cells from a culture system of SCs in suspension, the method further comprising incubating said undifferentiated SCs in culture system that support respectively, spontaneous or directed differentiation of SCs into the selected population of somatic cells. The present application also discloses a culture system for expansion of stem cells (SCs) comprising a suspension of undifferentiated stem cells within basic medium and knockout serum replacement (KOSR). The methods and culture system of the invention may be used for large scale production of differentiated cells.